RxDoctor Payments Data

Hannah Morris, PA

Physician Assistant · Monroe, LANPI 1427335249

Payments from drug & device makers

$919in general payments, 2019–2025

Across 40 payments — averaging $22.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$353
  • Urogen Pharma, Inc.$142
  • Urovant Sciences Inc$115
  • Johnson & Johnson$63
  • Sumitomo Pharma America, Inc.$51
  • Teleflex LLC$33
  • plus $162 from 8 others

What the payments were for

  • Food & beverage$81989%
  • Education$10011%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$919 in reported general payments places this provider in the 65th percentile of 1,246 physician assistant providers in Louisiana.

See all physician assistant providers in Louisiana

Medicare billing

Part B allowed, 2024
$60,137
Medicare patients
440
Services billed
1,417

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron127$69,538
GemtesaVibegron21$11,870
Mirabegron ErMirabegron23$11,031
Tamsulosin Hcl384$5,554
Oxybutynin Chloride ErOxybutynin Chloride191$3,721
Estradiol52$3,148
Finasteride189$2,509
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst54$2,184
Potassium Citrate ErPotassium Citrate41$1,834
Methenamine Hippurate26$1,308
NitrofurantoinNitrofurantoin Macrocrystal35$1,012
Solifenacin Succinate38$992
Testosterone Cypionate43$767
Ciprofloxacin Hcl71$224
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav29$191

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$353$69,538127 claims
Sumitomo Pharma America, Inc.Gemtesa$51$11,87021 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,246 physician assistant providers in Louisiana.

Other physician assistant in Monroe

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →